ロード中...
Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
Cannabidiol (CBD) is ubiquitous in state-based medical cannabis programs and consumer products for complementary health or recreational use. CBD has intrinsic pharmacologic effects and associated adverse drug events (ADEs) along with the potential for pharmacokinetic and pharmacodynamic drug–drug in...
保存先:
| 出版年: | J Clin Med |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6678684/ https://ncbi.nlm.nih.gov/pubmed/31288397 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8070989 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|